Global Genomic Biomarkers Market Enhancement Study by F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Inc – KSU

Genomic Biomarkers market research report performs the methodical and comprehensive market research study that puts forth the facts and figures linked with any subject about healthcare industry. The report provides with the complete knowledge and information of rapidly changing market landscape, what is already there in the market, future trends or market expectations, the competitive environment, and competitor strategies that aids in planning strategies with which business can outshine the competitors. A reliable Genomic Biomarkers report brings into focus plentiful of factors such as the general market conditions, trends, inclinations, key players, opportunities, and geographical analysis which all aids to take business towards the growth and success.

Global genomic biomarkers market is set to witness a healthy CAGR of 17.65% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of colorectal cancer and rising awareness about benefit of biomarker to treat fatal diseases are the major factor for the growth of this market.

Download Sample Copy of Report

Few of the major competitors currently working in the global genomic biomarkers market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Inc., MedGenome, Almac Group, Transgenomic Ltd, Sema4., GENOME LIFE SCIENCES, Creative Diagnostics, Cancer Genetics Inc., FOUNDATION MEDICINE, INC. CENTOGENE AG,,  Quanterix., and others

Key Developments in the Market:

In September 2018, Cancer Genetics, Inc. and NovellusDx, Ltd announced that they have signed an agreement according to which they are going to merge so that they can combine their data set and test portfolio associated to tumor biology. The main aim of the acquisition is to expand their therapeutic development and provide better treatment to the patient and biopharma companies

In February 2015, Roche announced that they have acquired Signature Diagnostics AG so that they can advance their translational research for their generating sequencing diagnostics. The main aim of the acquisition is to develop their NGS assays using cfDNA so that they can create non- invasive treatment for cancer patients

Market Drivers

Increasing demand for minimally invasive procedure will drive the market

Technological advancement and development in clinical laboratory tests will propel market

Increasing cases gastric and ovarian cancer will also act as a driver for this market

Rising demand for genomic biomarker based medicine will also contribute as a factor for the growth of this market

Market Restraints

Difficulty related with the process of genomics biomarker will also restrain the market

Strict government regulation will also restrain the growth of this market

Inquiry For Customize Report With Discount at :

Points to focus in the report

  1. The report offers market share appraisals for regional and global levels
  2. To gain detailed overview of parent market
  3. Information about key drivers, restraints, opportunities, and their impact analysis on the market size has been provided. 
  4. The study provides an in-depth analysis of the global order management software market and current & future trends to elucidate imminent investment pockets.
  5. Analyze and forecast Genomic Biomarkers market on the basis of type, function and application.

Segmentation: Global Genomic Biomarkers Market

By Application


Cardiovascular diseases

Neurological diseases


By End- User

Diagnostic and research laboratories



By Geography

North America

South America


Middle East and Africa

Get detailed toc @

Potential of the report

  1. To gain information about the top players in this industry, their product portfolios, and their key strategies.
  2. Key parameters which are driving this market and restraining its growth
  3. What all challenges manufacturers will face as well as new opportunities and threats faced by them.
  4. Learn about the market strategies that are being adopted by your competitors and leading organizations
  5. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research

Tel: +1-888-387-2818


Source link

Most Popular

To Top